Advertisement
Advertisement
SEER
Seer, Inc. Class A Common Stock
1.87
USDSponsored
+0.07
+3.89%
Sep 24, 15:59 UTC -4
Closed
Pre-Market
1.85
-0.02
-0.80%
SEER Earnings Reports
Positive Surprise Ratio
SEER beat 15 of 23 last estimates.
65%
Next Report
Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.23M
/-$0.25
Implied change from Q2 26 (Revenue/ EPS)
+36.46%
/-19.35%
Implied change from Q3 25 (Revenue/ EPS)
+2.72%
/-21.88%
Seer, Inc. Class A Common Stock earnings per share and revenue
On Aug 11, 2026, SEER reported earnings of -0.31 USD per share (EPS) for Q2 26, missing the estimate of -0.27 USD, resulting in a -12.56% surprise. Revenue reached 3.10 million, compared to an expected 3.62 million, with a -14.33% difference. The market reacted with a -0.93% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.25 USD, with revenue projected to reach 4.23 million USD, implying an decrease of -19.35% EPS, and increase of 36.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AnaptysBio, Inc. Common Stock
Report Date
Sep 21, 2026 For Q2 26
Estimate
$0.00
Actual
$5.11
Surprise
>+10,000.00%
BlossomHill Therapeutics, Inc. Common Stock
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$1.03
Actual
-$8.75
Surprise
-746.56%
Vogenx Inc Common Stock
Report Date
Sep 17, 2026 For Q2 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+1.96%
Benitec Biopharma Inc. Common Stock
Report Date
Sep 14, 2026 For Q4 26
Estimate
-$0.27
Actual
-$0.26
Surprise
+5.59%
Abivax SA - ADR
Report Date
Sep 21, 2026 For Q2 26
Estimate
-$1.82
Actual
-$2.09
Surprise
-14.47%
AYTU BioPharma, Inc. Common Stock
Report Date
Sep 22, 2026 For Q4 26
Estimate
-$0.33
Actual
-$0.05
Surprise
+84.92%
Neuphoria Therapeutics Inc. Common Stock
Report Date
Sep 18, 2026 For Q4 26
Estimate
-$0.57
Actual
-$0.95
Surprise
-66.32%
NewcelX Ltd. Ordinary Shares
Report Date
Sep 18, 2026 For Q2 26
Estimate
-$0.54
Actual
-$0.96
Surprise
-77.58%
FAQ
What were Seer, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Seer, Inc. Class A Common Stock reported EPS of -$0.31, missing estimates by -12.56%, and revenue of $3.10M, -14.33% below expectations.
How did the market react to Seer, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved down -0.93%, changed from $2.16 before the earnings release to $2.14 the day after.
When is Seer, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 04, 2026.
What are the forecasts for Seer, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Seer, Inc. Class A Common Stock is expected to report EPS of -$0.25 and revenue of $4.23M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.